Skip to main content
OpenTrials

Clinical trial condition

Refractory Leukemia

Explore clinical trials studying Refractory Leukemia. Study availability and eligibility vary by location and protocol.

14 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Refractory Leukemia trial results

Recruiting

A Study of Revumenib and Mezigdomide in People With Leukemia

NCT07356154

Conditions
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +18 more
Locations
  • City of Hope Cancer Center (Data collection only) Duarte, California, United States
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
View Trial Details
Completed

Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children

NCT02512926

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Stanford University School of Medicine and Stanford Cancer Institute Palo Alto, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions